Pilot Study on Evaluating the Geroprotective Effect of Metformin

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Metformin, Aging

In brief

The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.

Key facts

Study ID
NCT06459310
Run by
Xuanwu Hospital, Beijing
People needed
130
Starts
2024-06-30
Expected to finish
2028-07-31
Last updated by the study team
2025-03-21

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.